• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Vaccination Protects Against Pandemic H1N1 Infection in Sickle Cell Disease Mice

tetano

Editor, Senior Moderator
Viral Immunol. 2018 Apr 24. doi: 10.1089/vim.2018.0024. [Epub ahead of print]
[h=1]Influenza Vaccination Protects Against Pandemic H1N1 Infection in Sickle Cell Disease Mice.[/h] Roberts S[SUP]1[/SUP], Metzger DW[SUP]1[/SUP], Szczepanek SM[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza infection is associated with enhanced pathology in individuals with sickle cell disease (SCD). Despite being a high priority group for annual influenza vaccination, little is known about long-term responses to influenza vaccination in this patient population. To model flu vaccination, we inoculated SCD and wild type (WT) littermate mice with the seasonal flu vaccine [containing pandemic H1N1 (pH1N1) antigen], bled the mice before and after vaccination, and intranasally challenged them with a high dose (400 PFU) of pH1N1 12 weeks later. Both WT and SCD mice were fully protected from infection, and anti-influenza immunoglobulin G titers were significantly elevated in both groups after vaccination. It appears that flu vaccination is effective in SCD mice and our data support the clinical practice of regular flu vaccination in SCD patients.


[h=4]KEYWORDS:[/h] H1N1; influenza; sickle cell disease

PMID: 29688839 DOI: 10.1089/vim.2018.0024
 
Back
Top Bottom